166 related articles for article (PubMed ID: 10264767)
1. Brands or generics: the dilemma of pharmaceutical marketing in a developing country.
Quraeshi ZA; Luqmani M; Malhotra N
J Health Care Mark; 1983; 3(4):27-37. PubMed ID: 10264767
[TBL] [Abstract][Full Text] [Related]
2. The brand name versus generic controversy: Is there a segment of the pharmaceutical industry that produces drugs of higher quality?
Marsh DA; Hoar ME
Contemp Pharm Pract; 1982; 5(2):130-5. PubMed ID: 10317245
[TBL] [Abstract][Full Text] [Related]
3. The effect of generic competition on the price of brand-name drugs.
Lexchin J
Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
[TBL] [Abstract][Full Text] [Related]
4. What's in a name? Generics and the persistence of the pharmaceutical brand in American medicine.
Greene JA
J Hist Med Allied Sci; 2011 Oct; 66(4):468-506. PubMed ID: 20858701
[TBL] [Abstract][Full Text] [Related]
5. Competition between brand-name and generics--analysis on pricing of brand-name pharmaceutical.
Kong Y
Health Econ; 2009 May; 18(5):591-606. PubMed ID: 18816580
[TBL] [Abstract][Full Text] [Related]
6. [An analysis of the pharmaceuticals market in Vietnam].
Simonet D
Sante; 2001; 11(3):155-60. PubMed ID: 11641078
[TBL] [Abstract][Full Text] [Related]
7. When medicine becomes a disease.
Arabia; 1986 Mar; 5(55):32-6. PubMed ID: 12340711
[TBL] [Abstract][Full Text] [Related]
8. Is the pharmaceutical market in Bulgaria innovative?
Stoimenova A; Stankova M; Samev K; Petrova G
Boll Chim Farm; 2003 Sep; 142(7):260-3. PubMed ID: 14677267
[TBL] [Abstract][Full Text] [Related]
9. Some drugs more equal than others: pseudo-generics and commercial practice.
Probyn AJ
Aust Health Rev; 2004 Nov; 28(2):207-17. PubMed ID: 15527401
[TBL] [Abstract][Full Text] [Related]
10. [Early achievements of the Danish pharmaceutical industry-7].
Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
Theriaca; 2014; (42):31-62. PubMed ID: 25816561
[TBL] [Abstract][Full Text] [Related]
11. Status of generic substitution: problematic drug classes reviewed.
Ross MB
Hosp Formul; 1989 Aug; 24(8):441-4, 447-9. PubMed ID: 10294356
[TBL] [Abstract][Full Text] [Related]
12. Generics market in Greece: the pharmaceutical industry's beliefs.
Geitona M; Zavras D; Hatzikou M; Kyriopoulos J
Health Policy; 2006 Nov; 79(1):35-48. PubMed ID: 16386326
[TBL] [Abstract][Full Text] [Related]
13. Global marketing of cholesterol-lowering drugs as therapy.
Elimimian JU; Gilmore JM; Singletary TJ
J Hosp Mark Public Relations; 2006; 16(1-2):15-28. PubMed ID: 17194684
[TBL] [Abstract][Full Text] [Related]
14. Generic vs. brand name drugs--quality, not cost, is key issue.
Stetler CJ
Internist; 1979 May; 20(4):9-10, 12. PubMed ID: 10242133
[No Abstract] [Full Text] [Related]
15. The strategic response by pharmaceutical firms to the Medicaid most-favored-customer rules.
Scott Morton F
Rand J Econ; 1997; 28(2):269-90. PubMed ID: 11794358
[TBL] [Abstract][Full Text] [Related]
16. The generics in transplantation and the rules on their use.
Masri M
Exp Clin Transplant; 2003 Jun; 1(1):65-8. PubMed ID: 15859910
[TBL] [Abstract][Full Text] [Related]
17. Pharmaceutical research: paradox, challenge or dilemma?
Sheikh AL
East Mediterr Health J; 2006; 12 Suppl 1():S42-9. PubMed ID: 17037688
[TBL] [Abstract][Full Text] [Related]
18. Sharing, samples, and generics: an antitrust framework.
Carrier MA
Cornell Law Rev; 2017; 103(1):1-64. PubMed ID: 29236427
[TBL] [Abstract][Full Text] [Related]
19. How global brands compete.
Holt DB; Quelch JA; Taylor EL
Harv Bus Rev; 2004 Sep; 82(9):68-75, 136. PubMed ID: 15449856
[TBL] [Abstract][Full Text] [Related]
20. Does brand differentiate pharmaceuticals?
Bednarik J
Neuro Endocrinol Lett; 2005 Dec; 26(6):635-52. PubMed ID: 16380705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
